 NEBULIZED FORMULATION BEING DEVELOPED TO IMPROVE LUNG FUNCTION IN BOTH ACTIVE-DISEASE COVID-19 PATIENTS AND LONG HAUL PATIENTS WITH POST-INFECTION PULMONARY DISEASE NEBULIZED FORMULATION BEING DEVELOPED TO IMPROVE LUNG FUNCTION IN BOTH ACTIVE-DISEASE COVID-19 PATIENTS AND LONG HAUL PATIENTS WITH POST-INFECTION PULMONARY DISEASE 